Product

OM-89

Aliases

OM-89 [Uro-Vaxom® Capsule], Test Group(OM-89 group)

1 clinical trial

3 indications

Indication

Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Indication

Chronic Prostatitis

Indication

Chronic Pelvic Pain Syndrome

Clinical trial

A Multicenter, Randomized, Placebo-controlled, Double-blind, Phase 4 Study to Evaluate the Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Status: Recruiting, Estimated PCD: 2025-12-30